期刊文献+

高校教师心血管疾病危险性评估及干预 被引量:1

Evaluation and Intervention on Risk of Cardiovascular Disease in College Teacher
暂未订购
导出
摘要 目的探讨对高校教师心血管事件一级预防的措施及可行性.方法通过互联网(http://www.intmed.mcw.edu/clincalc/heartrisk.html)输入年龄、性别、吸烟史、糖尿病史、血压和血脂等参数,计算Framingham危险评分.对受试者进行调脂药物氟伐他汀钠(来适可)胶囊40mg,每日一次,睡前吞服干预治疗.8周后再度计算Framingham危险评分.治疗前后结果进行统计学分析、比较.结果受试者Framingham危险评分干预前为0.091±0.213,干预后为0.087±0.307(P<0.01),干预前后Framingham危险评分具显著性统计学差异.结论对心血管疾病主要危险因素血脂进行干预,可显著降低高校教师心血管事件发生率. To discuss the measures and feasibility of the primary prevention of cardiovascular diseases in college teachers. Framingham risk scores were Calculated through internet(http ://www. intmed. mew. edu/elincalc/hcartrisk, html) by inputting age, scx, smoking history, diabetes, blood pressure and blood lipid. Volunteers were treated with Fluvastatin 40 mg once a day respectively for 8 weeks. The changes of Framingham risk score before and aficr treatment were comparcd. SAS 8. I software was used for statistics analysis. The results showed that the Framingham risk scores were 0. 091±0. 213 before treatment and 0. 087 ±0.307 after treatment with significant difference. The results suggestcd that the intervention measures of lipoprotein may decrease the morbidity and mortality of cardiovascular events in college teachers distinctly. 9refs.
出处 《湖南环境生物职业技术学院学报》 CAS 2007年第4期26-28,共3页 JOurnal of Hunan Environment Biological Polytechnic
关键词 Framingham危险评分 血脂 干预 Framingham risk score lipoprotein intervention.
  • 相关文献

参考文献9

  • 1.Randomised trial of cholesterol lowering in4444patients with coronary heart disease:the Scandinavian Simvasta-tin Survival Study[4S][].The Lancet.1994
  • 2Sacks FM,Pfeffer MA,Moy LA,et al.The effect of pravastatin on coronary events after myocardial infarctionin patients with average cholesterol levels.Cholesterol and Recurrent Events Trial investigators[].The New England Journal of Medicine.1996
  • 3.The Long-Term Intervention with Pm、astatin in Ischae-mic Disease[LIPID]Study Group.Prevention of cardio-vascular events and death with pravastatin in patients with coronary heart disease and a broad rangeofinitial cholesterol levels[].The New England Journal of Medicine.1998
  • 4Shepherd J,Cobbe SM,Ford I,et al.Prevention of coronary disease in men with hypercholesterolemia.West of Scotland Coronary Prevention Study[WOSCOPS]Group[].The New England Journal of Medicine.1995
  • 5Downs JR,Clearfield M,Weis S,et al.Primary pre-vention of acute coronary events with lovastatin in men and women with average cholesterol levels:results of AFCAPS/TexCAPS.Air Force/Texas Coronary Athero-sclerosis Prevention Study[].The Journal of The American Medical Association.1998
  • 6Shepherd J,Blauw GJ,Murphy MB,et al.Pravastatin in elderly individuals at risk of vascular disease[PROS-PER]:a randomized controlled trial[].The Lancet.2002
  • 7Wilson P D,Agostino R,Levy D,et al.Prediction of coronary heart disease using risk factor categories[].Circulation.1998
  • 8Cannon CP,B raunwald E,M cCabe CH,et al.Intensive versusModer-ate L ip id Lowering w ith Statins after Acute Coronary Syndrom es[].NEngl JM ed.2004
  • 9LaRosa JC,Grundy SM.Intensive lip id lowering with atorvastatin in patients with stable coronary disease[].New England Journal of Medicine The.2005

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部